Seguici su acebook facebook Cerca nel sito:

Le ricerche di Gerona 2005

(17-06-13) Splenda and sucralose proven to contribute to development of diabetes


by Jonathan Benson, staff writer

(NaturalNews) One of the world's most popular non-caloric sweeteners has
recently been exposed as a complete fraud. A new study published in the journal
Diabetes Care reveals that Splenda (sucralose), which is commonly marketed to
diabetics as a safe, non-nutritive sweetener (NNS), actually elicits a diabetes-
promoting effect in people who consume it.

Researchers from the Center for Human Nutrition at the Washington University
School of Medicine in St. Louis, Missouri, made this discovery after evaluating
the metabolic effects of consuming Splenda on a small group of 17 human
participants, all of whom were obese and who did not consume artificial
sweeteners at the beginning of the study. Each participant was subjected to
either Splenda or control water 10 minutes prior to undergoing a five-hour
glucose tolerance test.

At the conclusion of the randomized crossover trial, the team observed that
Splenda consumption prompted noticeable changes in terms of insulin production,
circulating insulin levels, and bodily sensitivity to insulin. As relayed by
GreenMedInfo.com, a single dose of Splenda was found to increase plasma glucose
concentrations by 0.6 nanomoles per liter (nmol/L). It also led to a 20 percent
spike in insulin levels, a 22 percent increased peak insulin secretion rate, a
7 percent decrease in insulin clearance, and a 23 percent decrease in insulin
sensitivity.

"Compared with the control condition, sucralose ingestion caused 1) a greater
incremental increase in peak plasma glucose concentrations, 2) a ... greater
incremental increase in insulin area under the curve (AUC), 3) a ... greater
peak insulin secretion rate, 4) a ... decrease in insulin clearance, and 5) a
... decrease in SI (insulin sensitivity)," wrote the authors in their abstract.
"These data demonstrate that sucralose affects the glycemic and insulin
responses to an oral glucose load in obese people who do not normally consume
NNS."

Splenda also linked to causing gastrointestinal upset, migraine headaches and
environmental damage
This is all quite shocking, especially when considering that Splenda's entire
existence is predicated on the notion that it is a safe and acceptable
sweetening substitute for refined sugar products, which are widely known to
spike blood glucose levels and trigger excess insulin production. Many
diabetics use Splenda because they have been told that it has a minimal effect
on blood sugar levels, and is approved by the U.S. Food and Drug Administration
(FDA).

But it gets worse. Not only has Splenda now been shown to be detrimental for
diabetics, but it has also previously been shown to cause a host of other
health problems. A 2011 study published in the Canadian Journal of
Gastroenterology, for instance, identified a link between sucralose consumption
and inflammatory bowel disease (IBD). And a 2008 study published in the Journal
of Toxicology and Environmental Health, Part A found that consumption of
Splenda well below the FDA's acceptable daily intake levels disrupted gut flora
in test rats.

Beyond this, Splenda has also been linked to causing migraine headaches, and
numerous studies have found that the sweetening chemical is persistent in the
environment. According to information compiled by GreenMedInfo.com, the
discovery of sucralose, Splenda's primary active ingredient, was an accident --
pesticide researchers stumbled upon it after observing that it is closely
related to the retired insecticide chemical DDT.

"Industry influence largely accounts for the fact that synthetic chemicals
like aspartame, neotame, saccharin and sucralose are being foisted onto the
public as 'safe,' non-calorie sweeteners, despite obvious research to the
contrary," writes Sayer Ji for GreenMedInfo.com.

Sources for this article include:

http://www.greenmedinfo.com

http://www.ncbi.nlm.nih.gov/pubmed/21912763

http://www.ncbi.nlm.nih.gov/pubmed/18800291


News

  • (30-08-2018) The electronics in fluorescent bulbs and light emitting diodes (LED), rather than ultraviolet radiation, cause increased malignant melanoma incidence in indoor office workers and tanning bed users

    Leggi tutto

  • (30-08-2018) Mitocondri e peso forma

    Leggi tutto

  • (29-08-2018) Stroke now impacting younger patients as a result of the obesity epidemic; 4 in 10 are now aged 40-69

    Leggi tutto

  • (29-08-2018) Perdere peso non vuol dire perdere osso!

    Leggi tutto

  • (29-08-2018) Brain cholesterol: long secret life behind a barrier.

    Leggi tutto

  • (29-08-2018) Stile di vita sano? Si può, basta usare la fantasia

    Leggi tutto

  • (22-08-2018) Top 10 medical treatments that can make you SICKER than before you took them

    Leggi tutto

  • (22-08-2018) Meno ansia - C’è una associazione tra dieta e disturbi mentali?

    Leggi tutto

  • (22-08-2018) Dietary curcumin supplementation attenuates inflammation, hepatic injury and oxidative damage in a rat model of intra-uterine growth retardation.

    Leggi tutto

  • (22-08-2018) Dopo la gravidanza - Una dieta a basso indice glicemico se serve perdere peso

    Leggi tutto

  • (21-08-2018) Sleep Disturbances Can Be Prospectively Observed in Patients with an Inactive Inflammatory Bowel Disease.

    Leggi tutto

  • (21-08-2018) Anche i neo-papà soffrono della depressione post partum

    Leggi tutto


In evidenza

"L'informazione presente nel sito serve a migliorare, e non a sostituire, il rapporto medico-paziente."

Per coloro che hanno problemi di salute si consiglia di consultare sempre il proprio medico curante.

Informazioni utili